Alopecia Areata: all 469 studies

Page 4 of 5. Open to participants first (91), then studies with results posted, then the rest; newest registration first within each.

• Efficacy Study of Cosmetic Product Against Telogen Effluvium on WomenCompletedNCT04652232Not applicable
• Low Level Light Device as a Primary Therapy for Androgenetic AlopeciaStatus unknownNCT04558242Not applicable
• Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced AlopeciaCompletedNCT04554732Early Phase 1
• the Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose AscendingCompletedNCT04502901Phase 1
• Topical Cetirizine in Androgenetic Alopecia in FemalesCompletedNCT04481412Phase 2/3
• Hair Transplantation in Cicatricial AlopeciaCompletedNCT04472715Not applicable
• A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair LossCompletedNCT04450602Not applicable
• A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair LossCompletedNCT04450589Not applicable
• A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia AreataActive, not recruitingNCT04445363Phase 1/2
• Safety and Efficacy of HST 001 in Male Pattern Hair LossCompletedNCT04435847Phase 1
• Modified SALT Score for Alopecia AreataStatus unknownNCT04412148Phase 4
• HairDx Analytical Validation StudyWithdrawnNCT04379583
• A Phase II Study in Patients With Alopecia AreataCompletedNCT04346316Phase 2
• Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needlingCompletedNCT04338295Not applicable
• Topical Crisaborole in Patients with Alopecia AreataWithdrawnNCT04299503Phase 2
• Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic AlopeciaStatus unknownNCT04293822Phase 4
• Quality of Life Comparison in Patients With Different Types of AlopeciaCompletedNCT04246957
• The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataCompletedNCT04239521
• Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia AreataWithdrawnNCT04238091Phase 2
• Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional SteroidsStatus unknownNCT04228029Phase 4
• A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for AlopeciaCompletedNCT04205214Not applicable
• Efficacy of Platelet-Rich Plasma Therapy for Androgenetic Alopecia: A Systematic Review and Meta-analysisStatus unknownNCT04191005
• Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia AreataCompletedNCT04147845Not applicable
• Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair LossCompletedNCT04090801Phase 4
• Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Peri-menopausal and Menopausal Women With Thinning HairCompletedNCT04048031Not applicable
• PBMT for the Management of CIA ( HAIRLASER )Status unknownNCT04036994Not applicable
• Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia AreataCompletedNCT04034134Phase 2
• Clinical Application of Stem Cell Educator Therapy in Alopecia AreataActive, not recruitingNCT04011748Phase 2
• Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia AreataStatus unknownNCT04003376Phase 4
• Low Level Light Therapy (LLLT) for Hair GrowthStatus unknownNCT03938948Not applicable
• Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia AreataActive, not recruitingNCT03898479Phase 2/3
• The Effectiveness of Mindfulness Based Cognitive Group Therapy for Social Anxiety Symptoms in People Living With Alopecia AreataCompletedNCT03873155Not applicable
• Laser Assisted Delivery of Minoxidil in Androgenetic AlopeciaWithdrawnNCT03852992Phase 2
• Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia AreataCompletedNCT03847441Not applicable
• Efficacy and Safety of DIGNICAP™ SystemCompletedNCT03712696Not applicable
• Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and LossTerminatedNCT03709563Not applicable
• Androgenetic Alopecia and the JAK-STAT PathwayCompletedNCT03694067
• Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic AlopeciaCompletedNCT03676400Not applicable
• A Longitudinal Observational Study of Patients Undergoing Therapy for IMISCActive, not recruitingNCT03661866
• Radiation- Induced Alopecia in Patients Undergoing Radiation Therapy to the BrainTerminatedNCT03543020
• Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia AreataCompletedNCT03535233Phase 4
• Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia AreataWithdrawnNCT03532958Phase 2
• Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic EvaluationStatus unknownNCT03473600Phase 4
• Autologous Adipose-Derived Adult Stromal Vascular Cell Transplantation for AlopeciaStatus unknownNCT03427905Not applicable
• Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing AlopeciaStatus unknownNCT03422640Phase 4
• Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit ExtractionStatus unknownNCT03388840Phase 4
• ENERGI-F701 for Female Hair Loss TreatmentCompletedNCT03351322Phase 2
• Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring AlopeciaCompletedNCT03346668Early Phase 1
• Platelet Rich Plasma for Frontal Fibrosing AlopeciaWithdrawnNCT03335228Not applicable
• "iRestore" Light Therapy ApparatusCompletedNCT03331003Not applicable
• Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.TerminatedNCT03325296Phase 2
• Fraxel Laser for AlopeciaWithdrawnNCT03284021Not applicable
• Relevance of Trichoscopy in Differential Diagnosis of Focal Non-cicatricial Alopecia in ChildrenCompletedNCT03260777
• Concomitant Limb Cryocompression and Scalp Cooling to Reduce Paclitaxel-induced Neuropathy and AlopeciaStatus unknownNCT03248193Not applicable
• Efficacy and Safety of LH-8 in Paediatric Alopecia AreataCompletedNCT03240627Phase 2/3
• Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning HairCompletedNCT03206567Not applicable
• Ocular Finding in Alopecia AreataStatus unknownNCT03155958
• Role of Vitamin D in Androgenetic AlopeciaStatus unknownNCT03154528
• Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in FemalesCompletedNCT03052413Not applicable
• The Effect of Platelet-rich Plasma in Subjects With Androgenetic AlopeciaWithdrawnNCT03048461Phase 2
• Barriers to Care and QOL for CCCA PatientsCompletedNCT03044782
• Comparing Different Platelet Rich Plasma (PRP) Treatment Regimens for Management of Androgenic AlopeciaStatus unknownNCT02999737Phase 4
• Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)CompletedNCT02919735Phase 2
• Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic AlopeciaCompletedNCT02865421Phase 2
• Efficacy of the Use of Refrigerant Helmet to Prevent Alopecia in Patients Treated With Eribulin for Breast CancerTerminatedNCT02863146
• Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic AlopeciaCompletedNCT02848300Phase 1
• Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic AlopeciaCompletedNCT02824380Phase 1
• "Impact of Chemotherapy-induced Alopecia on the Quality of Life of Women With Breast Cancer"Status unknownNCT02797223
• Photosensitization Study in Androgenetic AlopeciaCompletedNCT02791243Phase 1
• Topical Garlic Concentrate for Alopecia Areata in ChildrenTerminatedNCT02691117Phase 3
• Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)TerminatedNCT02676310Phase 1
• Safety and Efficacy Study of SHAPE Gel in Alopecia AreataStatus unknownNCT02636244Phase 2
• Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and FemalesStatus unknownNCT02604888Not applicable
• The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic AlopeciaCompletedNCT02594046Not applicable
• Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia TreatmentCompletedNCT02591355Not applicable
• TREg Activation in the Treatment of the PELADE (Alopecia Areata)CompletedNCT02557074Phase 3
• PAI-1 Expression in Non-scarring Hair LossTerminatedNCT02548689
• Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PROStatus unknownNCT02528552Phase 2
• Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical MinoxidilWithdrawnNCT02486848Not applicable
• The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic AlopeciaWithdrawnNCT02483195Phase 4
• Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing AlopeciaStatus unknownNCT02467101Not applicable
• Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic AlopeciaStatus unknownNCT02393040Not applicable
• Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia AreataCompletedNCT02350023Phase 4
• Efficacy of the New Viviscal Professional Strength Oral Supplement in Females With Thinning HairCompletedNCT02302053Not applicable
• Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Thinning HairCompletedNCT02297360Not applicable
• To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning HairCompletedNCT02288858Not applicable
• Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical ApplicationCompletedNCT02280603Phase 1/2
• A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic AlopeciaCompletedNCT02279823Phase 2
• Minoxidil Response Testing in Females With Female Pattern Hair LossCompletedNCT02206802
• Minoxidil Response Testing in Males With Androgenetic AlopeciaCompletedNCT02198261
• Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic AlopeciaStatus unknownNCT02154503Phase 1
• Efficacy of Nutrition Supplement for Treatment of Men With Hair LossCompletedNCT02150187Phase 2
• Effect of PRP on the Therapy for Hair GrowthCompletedNCT02087319Not applicable
• Efficacy and Safety of Platelet Rich Plasma in Androgenetic AlopeciaStatus unknownNCT02074943Not applicable
• A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in MalesCompletedNCT02067260Not applicable
• The Efficiency Of The Methotrexate At Patients Affected By Grave PeladeCompletedNCT02037191Phase 3
• At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
• A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia AreataWithdrawnNCT01917058Phase 2
• A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair LossCompletedNCT01900041Phase 2
• Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic AlopeciaWithdrawnNCT01885676Not applicable

← Alopecia Areata overview